SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-20-053354
Filing Date
2020-02-28
Accepted
2020-02-27 19:07:19
Documents
8
Effectiveness Date
2020-02-28

Document Format Files

Seq Description Document Type Size
1 POSASR d865375dposasr.htm POSASR 587094
2 EX-1.2 d865375dex12.htm EX-1.2 192880
3 EX-5.3 d865375dex53.htm EX-5.3 51649
4 EX-23.4 d865375dex234.htm EX-23.4 1640
5 EX-23.5 d865375dex235.htm EX-23.5 1572
6 GRAPHIC g865375g0227144308343.jpg GRAPHIC 2740
7 GRAPHIC g865375g53z06.jpg GRAPHIC 38165
8 GRAPHIC g865375g66x13.jpg GRAPHIC 119338
  Complete submission text file 0001193125-20-053354.txt   1046026
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000
Type: POSASR | Act: 33 | File No.: 333-234439 | Film No.: 20664741
SIC: 2836 Biological Products, (No Diagnostic Substances)